HIV DNA vaccine regulated by a caev-derived promoter
    2.
    发明授权
    HIV DNA vaccine regulated by a caev-derived promoter 有权
    艾滋病毒DNA疫苗受caff来源的启动子调控

    公开(公告)号:US08916174B2

    公开(公告)日:2014-12-23

    申请号:US13185164

    申请日:2011-07-18

    摘要: The present invention is directed to a DNA vaccine for immunization against HIV. The invention comprises a DNA molecule that has a sequence encoding a plurality of viral proteins capable of stimulating an immune response against HIV. The DNA molecule is rendered safe for use as a vaccine by the disruption of genes encoding reverse transcriptase, integrase, and Vif. The DNA molecule is further rendered safe by at least a partial deletion of the 3′ LTR.

    摘要翻译: 本发明涉及用于免疫HIV的DNA疫苗。 本发明包括具有编码能够刺激针对HIV的免疫应答的多种病毒蛋白的序列的DNA分子。 通过破坏编码逆转录酶,整合酶和Vif的基因,DNA分子被安全地用作疫苗。 通过至少部分删除3'LTR,进一步使DNA分子变得安全。